Clinical Trials Logo

Optic Nerve Disease clinical trials

View clinical trials related to Optic Nerve Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT04607369 Enrolling by invitation - Macular Disease Clinical Trials

Implementation of the NEDS EyeCTester App

Start date: January 9, 2019
Phase:
Study type: Observational

Group 4a and 4b was an FDA trial that showed that patients who have an Amsler grid abnormality on paper, have a similar abnormality on the app. Group 7a and 7b was an FDA trial that showed that normal patients do not have false positives on the Amsler app as well as on the Amsler paper version. Further Vision on the app is slightly better than vision on the standard Sloan near card using a formula (vision is 7/10th of a line better on the app).

NCT ID: NCT03011541 Recruiting - Glaucoma Clinical Trials

Stem Cell Ophthalmology Treatment Study II

SCOTS2
Start date: January 2016
Phase: N/A
Study type: Interventional

This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.

NCT ID: NCT01920867 Enrolling by invitation - Glaucoma Clinical Trials

Stem Cell Ophthalmology Treatment Study

SCOTS
Start date: August 2012
Phase: N/A
Study type: Interventional

This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease. http://mdstemcells.com/scots-ii/